IFNG and melanoma: Furthermore, functional assays using mice with melanoma that are resistant to anti-CTLA-4 Ab plus radiation therapy revealed that inhibition of tumor IFN-γ signaling decreases ISGs in cancer cells, while it increases the number and IFN-γ production of CD8+ T cells and activates NK cells in melanoma.